Urology · Media, PA
NPI
1366609448
Since 2008
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
200 State Street, Suite 205
Media, PA, 19063
Phone (610) 521-4112
Groups this clinician bills Medicare through
Medicare paid, 2024
$434K
21,858 services
Medicare patients, 2024
808
Average age 77
Drug cost, 2024
$8.2M
2,811 prescriptions
Company payments, 2025
$27K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George Dakwar was code J0897 (injection, denosumab, 1 mg), 6,420 times for 21 patients. In total George Dakwar billed 21,858 services in 79 codes, and Medicare paid $434K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 6,420 | 21 | $20.53 | $132K |
| J9155 Injection, degarelix, 1 mg | Office | 3,680 | 14 | $3.32 | $12K |
| 81003 Clinical Chemistry | Office | 1,131 | 604 | $2.19 | $2,478 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,116 | 615 | $12.10 | $14K |
| 51798 Ultrasound - Nonspecific | Office | 992 | 570 | $8.43 | $8,367 |
| 99214 Office E&M - Established | Office | 816 | 488 | $92.14 | $75K |
| 36415 Venipuncture Blood Collection | Office | 744 | 464 | $8.64 | $6,427 |
| 99213 Office E&M - Established | Office | 515 | 358 | $64.08 | $33K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 389 | 81 | $48.50 | $19K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 301 | 44 | $140.60 | $42K |
| 51741 Test - Miscellaneous | Office | 173 | 138 | $10.84 | $1,875 |
| 52000 Cystourethroscopy | Facility | 167 | 129 | $55.21 | $9,219 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 131 | 67 | $38.20 | $5,004 |
| 96402 Chemotherapy Administration | Office | 126 | 56 | $26.84 | $3,382 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 112 | 28 | $0.35 | $38.8 |
By year: 2022 $621K for 15,557 services; 2023 $476K for 21,764 services; 2024 $434K for 21,858 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,131 | 604 | $2.19 | $2,478 |
| 36415 Venipuncture Blood Collection | 744 | 464 | $8.64 | $6,427 |
Medicare prescription drug claims, 2024
In 2024, the drug George Dakwar prescribed most often to Medicare patients was Orgovyx (Relugolix), with 730 prescriptions and refills. In total George Dakwar wrote 2,811 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 730 | 730 | 98 | $2.0M |
| Tamsulosin Hcl Generic | 474 | 1,261 | 211 | $7,308 |
| Xtandi Enzalutamide | 261 | 261 | 32 | $3.0M |
| Erleada Apalutamide | 163 | 163 | 18 | $2.2M |
| Alfuzosin Hcl Er Alfuzosin Hcl | 150 | 316 | 56 | $3,201 |
| Doxycycline Hyclate Generic | 91 | 105 | 72 | $996 |
| Abiraterone Acetate Generic | 83 | 83 | 12 | $162K |
| Prednisone Generic | 73 | 79 | 12 | $366 |
| Cephalexin Generic | 69 | 71 | 59 | $276 |
| Finasteride Generic | 68 | 198 | 28 | $833 |
| Nubeqa Darolutamide | 54 | 54 | Under 11 | $711K |
| Myrbetriq Mirabegron | 51 | 97 | 20 | $44K |
| Ciprofloxacin Hcl Generic | 38 | 38 | 31 | $99.74 |
| Bicalutamide Generic | 33 | 41 | 25 | $446 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 28 | 28 | 26 | $97.38 |
Brand drugs: - claims; generic drugs: 1,525 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George Dakwar $27K ($27K in general payments such as food, travel and fees) from 21 companies. The largest payer was Medtronic, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 7 | $18K |
| Janssen Biotech, Inc. JNJ | 20 | $4,192 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 17 | $2,260 |
| Pfizer Inc. PFE | 16 | $1,786 |
| Dendreon Pharmaceuticals LLC | 4 | $206 |
| Abbvie Inc. ABBV | 13 | $193 |
| Tolmar, Inc. | 8 | $153 |
| Immunitybio, Inc. IBRX | 3 | $151 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $150 |
| Astellas Pharma US Inc 4503.T | 6 | $126 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.